Skip to main content
OpenTrials
Completed

NCT Number: NCT05761353

Endermologie Versus Negative Pressure Therapy on Postmastectomy Lymphedema

Statement of the problem:

The problem will be stated in a questionary form:

"Which will be more effective endermologie or negative pressure therapy in reducing limb circumference and volume in postmastectomy lymphedema?".

Hypothesis:

It will be hypothesized that:

There is no significant difference between endermologie and negative pressure therapy in reducing circumference and limb volume in post mastectomy lymphedema.

Completed

Looking for future studies?

Notify Me

Key information

Age range

40 year–60 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Outpatient clinic, Faculty of Physical Therapy, Cairo university

Giza, Dokki, 11432, Egypt

About this study

Subject:

Sixty- eight women treated for unilateral breast cancer with secondary upper limb lymphedema post mastectomy will participate in this study. Their ages will be ranged from 40 to 60 years, they will be free from any other diseases that will affect or influence the results and the participants will be selected from National Cancer Institute and randomly distributed into two equal groups in number.

Study design:

In this study the patients will be randomly assigned into two groups equal in number (34 patients for each group).

Inclusion criteria

The subject selection will be according to the following criteria:

  • Only females will participate in the study.
  • Patients' age will be ranged between 40-60 years.
  • All patients will suffer from post mastectomy lymph-edema.
  • All patients have a modified radical mastectomy.
  • All patients will suffer from grade II lymph edema without skin changes one year post mastectomy.
  • All patients are right-dominant hand.
  • All patients enrolled to the study have their informed consent.

Exclusion criteria

The potential participants will be excluded if they meet one of the following criteria:

  • primary lymph-edema.
  • Diabetes mellitus.
  • Pregnancy.
  • Recurrent cancer.
  • Current or recent cellulitis.
  • Current metastases.
  • Venous thrombosis.
  • Photosensitivity.
  • Phlebitis in development stage.
  • Infection.
  • Receiving anti-coagulant treatment.

Equipment:

The study equipment's will be divided into measurement and therapeutic equipment and tools:

1: Measurement equipment

1(a):Limb volume measurement:

This will be performed by measuring the circumference of each segment of the limb between two consecutive circumferences as a truncated zone. The volume of the segment was calculated as:

V=h (c12+c1c2+c22 )/12π, where V is the volume of the segment, c1 and c2 are the circumferences at the ends of the segment, and h is the distance between them.

Measurement of limb volume measurement will be conducted pre-treatment and after treatment course (6 weeks).

  • (b): Measuring Disability of the arm, shoulder and hand by: .Quick DASH questionnaire (Disability of the arm, shoulder, and hand).
  • The Quick- DASH has five response options for each item from 0=no difficulty to perform or no symptoms to 5=unable to do.
  • Quick DASH scale will be conducted pre-treatment and after treatment course (6 weeks).
  • Therapeutic equipment :
  • a. Endermologie: endermologie therapy will be three sessions per week for six weeks (total 18 sessions).

The study group will receive 18 sessions by Endermologie system ( used to decrease postmastectomy lymphedema for group (A), three sessions per week for six weeks.

Each session was 30 minutes at the posterior thorax, upper arm, forearm and the hand.

2.b. Negative pressure therapy:

  • Pressure: 20-250 mm Hg.
  • Total treatment period: six weeks.
  • A number of sessions: 3 sessions/ week. Time of application : 30 min

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Only females will participate in the study.
  • Patients' age was ranged between 40-60 years.
  • All patients will suffer from post mastectomy lymphedema.
  • All patients have a modified radical mastectomy.
  • All patients suffer from grade II lymphedema without skin changes one year post mastectomy(as defined by the International Society of Lymphology).
  • All patients are right-dominant hand.
  • All patients enrolled to the study will have their informed consent.

Exclusion criteria

  • The potential participants will be excluded if they meet one of the following criteria:
  • primary lymphedema.
  • Diabetes mellitus.
  • Pregnancy.
  • Recurrent cancer.
  • Current or recent cellulitis.
  • Current metastases.
  • Venous thrombosis.
  • Photosensitivity.
  • Phlebitis in development stage.
  • Infection.
  • Receiving anti-coagulant treatment.

Treatment and study plan

Endermologie

Device

Group A will receive -18 sessions by Endermologie system used to decrease postmastectomy lymphedema for group (A), three sessions per week for six weeks.

Each session was 30 minutes at the posterior thorax, upper arm, forearm and the hand.

-In addition to physical therapy program (active range of motion and elevation); hygiene and skin care

negative pressure therapy

Device

Group B will receive negative pressure therapy with

  • Pressure: 20-250 mmHg.
  • Total treatment period: 6weeks
  • A number of sessions: 3sessions/ week. Time of application : 30 min
  • In addition to physical therapy program (active range of motion and elevation); hygiene and skin care

Primary outcomes

  1. Measuring Disability of the arm, shoulder and hand

    Time frame: Measuring will be taken before treatment and after 6 weeks of treatment to monitor the change in upper limb function before and after treatment

    Measuring Disability of the arm, shoulder and hand will be carried out by using Quick-DASH questionnaire

  2. Limb volume measurement

    Time frame: Measuring will be taken before treatment and after 6 weeks of treatment to monitor the change in upper limb volume and decrease of lymph-edema

    Limb volume measurement will be carried out by by measuring the circumference of each segment of the limb between two consecutive circumferences as a truncated zone. The volume of the segment was calculated as:

    V=h (c1+c1c2+c2 )/12π

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Mar 9, 2023
Registry last updated
Dec 27, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.